GIC enters joint venture with India-based mall developer-operator
Lisa Kriwangko
DeeperDive is a beta AI feature. Refer to full articles for the facts.
GIC has entered into a joint venture with Phoenix Mills, an India-based retail mall developer and operator, to establish an investment platform for retail-led mixed-use assets in India.
Under the agreement, Singapore's sovereign wealth fund will acquire a significant minority stake in Phoenix Mills' US$733 million portfolio of retail-led mixed-use developments, comprising about 3.4 million square feet of leasable retail and office space in the prime consumption centres of Mumbai and Pune.
Kishore Gotety, co-head of Asia (excluding China) real estate at GIC, said: "We recognise that the unprecedented global crisis is impacting consumer sentiment and that the necessary lockdown has made it challenging for all businesses, especially those in the retail sector.
"However, the long-term structural growth that the Indian retail industry continues to offer, due to favourable demographics, urbanisation, a growing middle class and increasing consumerism trends, will still benefit the joint venture."
Shishir Shrivastava, managing director of Phoenix Mills, said: "With multiple vaccines now feasible, we see a clear path towards turning the corner, past the second wave. As restrictions start relaxing, we are optimistic of a sharp rebound in consumption, as we experienced after the first wave."
The transaction is subject to relevant regulatory approvals, the sovereign wealth fund announced on Wednesday.
Decoding Asia newsletter: your guide to navigating Asia in a new global order. Sign up here to get Decoding Asia newsletter. Delivered to your inbox. Free.
Copyright SPH Media. All rights reserved.
TRENDING NOW
Air India asks Tata, Singapore Airlines for funds after US$2.4 billion loss
Beijing’s calculated silence on the Iran war
China pips the US if Asean is forced to choose, but analysts warn against reading it like a sports result
Richard Eu on how core values, customers keep Singapore’s TCM chain Eu Yan Sang relevant